Bacterial translocation across the intestinal mucosal barrier leads to a macrophagemediated inflammatory response, visceral hyperalgesia, and ileus. Our aim was to examine how mediators released into mesenteric lymph following LPS treatment influence intestinal afferent sensitivity and the role played by prostanoids in any sensitization. Intestinal lymph was collected from awake rats following treatment with either saline or LPS (5 mg/kg ip). Extracellular multiunit afferent recordings were made from paravascular mesenteric nerve bundles supplying the rat jejunum in vitro following arterial administration of control lymph, LPS lymph, and LPS. Mesenteric afferent discharge increased significantly after LPS lymph compared with control lymph. Peak discharge occurred within 2 min and remained elevated for 5 to 8 min. This response was attenuated by pretreatment with naproxen (10 M), and restored upon addition of prostaglandin E 2 (5 M) in the presence of naproxen, but AH6809 (5 M), an EP 1/EP2 receptor(s) antagonist, failed to decrease the magnitude of LPS lymph-induced response. LPS itself also stimulated mesenteric afferent discharge but was unaffected by naproxen. TNF-␣ was significantly increased in LPS lymph compared with control lymph (1,583 Ϯ 197 vs. 169 Ϯ 38 pg/ml, P Ͻ 0.01) but exogenous TNF-␣ failed to evoke any afferent nerve discharge. We concluded that inflammatory mediators released from the gut into mesenteric lymph during endotoxemia have a profound effect on afferent discharge. These mediators influence afferent firing via the release of local prostaglandins. cytokines; lymph; hypersensitivity A SMALL BUT SIGNIFICANT SUBGROUP of irritable bowel syndrome (IBS) patients can trace the onset of their symptoms to a bout of acute gastroenteritis (27). It has been suggested that in these postinfectious IBS patients an acute inflammatory insult leads to the development of chronic symptoms (27, 28) and while psychosocial factors play a major role, there is evidence that an augmented inflammatory response may be a predisposing factor (12). Certainly there is a wealth of evidence demonstrating that inflammatory mediators alter the sensitivity of intestinal afferents (18). Many IBS patients exhibit a lowered visceral sensory threshold to pain; thus it is conceivable that in postinfectious IBS that visceral hypersensitivity may be secondary to an inflammatory insult (28). Understanding the etiology of chronic changes in visceral hypersensitivity may therefore be of considerable benefit to patients with postinfectious IBS.LPS from Gram-negative bacteria, also known as endotoxin, can trigger a macrophage-driven cytokine cascade that is referred to as an acute-phase response. This drives a local inflammatory reaction and generates behavioral responses known as sickness behavior that include fever, anorexia, and hyperalgesia (21). In animal models, systemic LPS can cause ileus (8), rectal hypersensitivity (5), and also produces a profound increase in the afferent discharge emanating from the bowel wall (19). The mac...